Cargando…

Validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 Danish children

BACKGROUND AND AIMS: When investigating and treating asthma in children, diagnosing must be precise and valid. There is a need for studies researching asthma in children showing how to use registry‐based, epidemiological data. We examined the feasibility and validity of using anti‐asthmatic drug pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubak, Sune, Høst, Arne, Christensen, Lotte Brix, Langfrits, Mette Sørensen, Thomsen, Reimar Wernich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266370/
https://www.ncbi.nlm.nih.gov/pubmed/30623100
http://dx.doi.org/10.1002/hsr2.77
_version_ 1783375824129359872
author Rubak, Sune
Høst, Arne
Christensen, Lotte Brix
Langfrits, Mette Sørensen
Thomsen, Reimar Wernich
author_facet Rubak, Sune
Høst, Arne
Christensen, Lotte Brix
Langfrits, Mette Sørensen
Thomsen, Reimar Wernich
author_sort Rubak, Sune
collection PubMed
description BACKGROUND AND AIMS: When investigating and treating asthma in children, diagnosing must be precise and valid. There is a need for studies researching asthma in children showing how to use registry‐based, epidemiological data. We examined the feasibility and validity of using anti‐asthmatic drug prescription data to identify children with asthma and assessed medication patterns in children with and without confirmed asthma. METHODS: We used population‐based Danish prescription data and hospital discharge registries to identify all children aged 0 to 14 years who had redeemed at least one prescription for an inhaled anti‐asthmatic drug. Individual asthma cases were validated by hospital discharge information and by their treating general practitioners according to international asthma guidelines. RESULTS: In total, 2053 children, out of a population of 20181, had redeemed at least one prescription of any inhaled anti‐asthmatic drug. The positive predictive value (PPV) of having two different asthma medications prescribed in 1 year was 80.2% for presence of true asthma, with a sensitivity of 59%. Corresponding estimates of PPV/sensitivity of at least one prescription for an inhaled corticosteroid (ICS) were 79% and 58%, respectively, while the true asthma PPV with at least one LABA prescription increased to 97%. Among children with confirmed asthma, one‐third had not used Beta2‐agonist therapy as part of their treatment. Conversely, among children without confirmed asthma, 40% were prescribed a minimum of two prescriptions for any kind of inhaled anti‐asthmatic drug, and 12% and 9% used an ICS or Leukotriene receptor antagonist, respectively. CONCLUSIONS: Anti‐asthmatic drug prescription data could be used to identify children with true asthma, with reasonable accuracy. The observed pattern of anti‐asthmatic medication usage among children with and without confirmed asthma suggests that there is room for therapeutic improvement.
format Online
Article
Text
id pubmed-6266370
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62663702019-01-08 Validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 Danish children Rubak, Sune Høst, Arne Christensen, Lotte Brix Langfrits, Mette Sørensen Thomsen, Reimar Wernich Health Sci Rep Research Articles BACKGROUND AND AIMS: When investigating and treating asthma in children, diagnosing must be precise and valid. There is a need for studies researching asthma in children showing how to use registry‐based, epidemiological data. We examined the feasibility and validity of using anti‐asthmatic drug prescription data to identify children with asthma and assessed medication patterns in children with and without confirmed asthma. METHODS: We used population‐based Danish prescription data and hospital discharge registries to identify all children aged 0 to 14 years who had redeemed at least one prescription for an inhaled anti‐asthmatic drug. Individual asthma cases were validated by hospital discharge information and by their treating general practitioners according to international asthma guidelines. RESULTS: In total, 2053 children, out of a population of 20181, had redeemed at least one prescription of any inhaled anti‐asthmatic drug. The positive predictive value (PPV) of having two different asthma medications prescribed in 1 year was 80.2% for presence of true asthma, with a sensitivity of 59%. Corresponding estimates of PPV/sensitivity of at least one prescription for an inhaled corticosteroid (ICS) were 79% and 58%, respectively, while the true asthma PPV with at least one LABA prescription increased to 97%. Among children with confirmed asthma, one‐third had not used Beta2‐agonist therapy as part of their treatment. Conversely, among children without confirmed asthma, 40% were prescribed a minimum of two prescriptions for any kind of inhaled anti‐asthmatic drug, and 12% and 9% used an ICS or Leukotriene receptor antagonist, respectively. CONCLUSIONS: Anti‐asthmatic drug prescription data could be used to identify children with true asthma, with reasonable accuracy. The observed pattern of anti‐asthmatic medication usage among children with and without confirmed asthma suggests that there is room for therapeutic improvement. John Wiley and Sons Inc. 2018-07-24 /pmc/articles/PMC6266370/ /pubmed/30623100 http://dx.doi.org/10.1002/hsr2.77 Text en © 2018 The Authors. Health Science Reports published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Rubak, Sune
Høst, Arne
Christensen, Lotte Brix
Langfrits, Mette Sørensen
Thomsen, Reimar Wernich
Validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 Danish children
title Validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 Danish children
title_full Validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 Danish children
title_fullStr Validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 Danish children
title_full_unstemmed Validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 Danish children
title_short Validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 Danish children
title_sort validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 danish children
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266370/
https://www.ncbi.nlm.nih.gov/pubmed/30623100
http://dx.doi.org/10.1002/hsr2.77
work_keys_str_mv AT rubaksune validityofasthmadiagnosesandpatternsofantiasthmaticdruguseinacohortof2053danishchildren
AT høstarne validityofasthmadiagnosesandpatternsofantiasthmaticdruguseinacohortof2053danishchildren
AT christensenlottebrix validityofasthmadiagnosesandpatternsofantiasthmaticdruguseinacohortof2053danishchildren
AT langfritsmettesørensen validityofasthmadiagnosesandpatternsofantiasthmaticdruguseinacohortof2053danishchildren
AT thomsenreimarwernich validityofasthmadiagnosesandpatternsofantiasthmaticdruguseinacohortof2053danishchildren